ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Commodore Capital LP's Holding History (CIK: 0001831942)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,692,809 Value ($000) $72,269 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 4,692,809 Value ($000) $96,062 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 4,692,809 Value ($000) $94,138 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 4,675,000 Value ($000) $92,004 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 4,205,000 Value ($000) $94,613 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 4,100,000 Value ($000) $104,714 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 3,973,245 Value ($000) $92,855 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 3,973,245 Value ($000) $69,889 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 2,901,816 Value ($000) $40,161 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 2,901,816 Value ($000) $39,639 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 2,348,272 Value ($000) $47,928 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 1,731,365 Value ($000) $37,917 Avg Close $20.34 Range $14.56 - $25.34